Get 20% Free Customization In This Report

Buy this report from - $3690

Blood Market by Product [Whole Blood Collection (System and Reagents), Source Plasma Collections (System and Reagents) Blood Therapeutics (IVIG, Albumin, Hyperimmune, Factor VIII, Factor IX, and Others), Blood Typing Products (System and Reagents), Blood Screening (Systems and Reagents), Blood Processing Equipment & Associated Products (System and Reagents)] and End User (Blood & Blood Component Bank, Diagnostic Laboratories, Ambulatory Surgical Centers, Hospitals, and Others): Global Opportunity Analysis and Industry Forecast, 2017-2023

Diagnostics and Biotech	LI_172297	Pages: 63	May 2017 \| 2210 Views
Author's : Shubhangi Bawkar and Archana Kamble	Tables: 53	Charts: 38	Formats*:

Blood Market Overview:

Global Blood Market was valued at $33,500 million in 2016, and is estimated to reach $45,982 million by 2023, growing at a CAGR of 4.6% from 2017 to 2023. Blood market involves the selling of whole blood & blood components through various channels, such as blood banks, hospitals, and others. The donor blood is collected and is segregated into required components for therapy purpose. A basic blood transfusion procedure involves the transfer of red blood cells from one person to another, usually at a hospital during a surgery. Whole blood is rarely utilized in transfusions anymore, and only the blood components are required by the recipient, owing to the advancement in the medical technology.

Increase in geriatric population, rise in incidence in trauma cases, technological advancement in medical technology for donor screening, and advancement in blood transfusion instruments are the major factors that drive the market growth. However, minimal invasive technology, which no longer need the blood transfusion, restrains the market growth. Improvement in the healthcare facilities in Asia-Pacific provide growth opportunities for the market.

Blood Market Market Segmentation

Segment Review

The global blood market is segmented based on product, end user, and geography. Based on product, it is classified into whole blood collection, source plasma collection, blood therapeutics, blood typing products, blood screening, and blood processing equipment & associated products. Blood therapeutics segment contributed the highest share in 2016, owing to the increase in the demand for various plasma proteins for the recovery of patients wellness. Further, based on whole blood collection, the market is bifurcated into systems and reagents. Source plasma collection is classified into system and reagents. Blood therapeutics are divided into intravenous immunoglobulin (IVIG), factor IX, factor VIII, hyperimmune, and albumins. Blood typing products are categorized into systems and reagents. Blood screening is divided into systems and reagents. Blood processing equipment & associated products are bifurcated into systems and reagents. Based on end user, the market is divided into blood & blood component bank, diagnostics laboratories, ambulatory surgical centers, hospitals, and others. Blood & blood component banks contributed highest share in 2016, owing to the increase in the demand for blood processing in the blood banks and for segregation of components in the blood.

Top Investment Pockets

Blood therapeutics is considered as the top investment pocket, owing to the significant growth opportunity. Blood therapeutics market is projected to grow at a highest CAGR of 5.0% during the analysis period, owing to the rise in demand for the use of blood components in treatments for fast recovery or healing purposes. Thus, the demand for blood components is high as compared to whole blood.

Top Investment Pockets for Global Blood Market

Geographical Analysis

Geographically, the market is divided into North America, Europe, Asia-Pacific, and LAMEA. North America held the leading position, owing to its well-developed healthcare industry and rise in number of patients population requiring blood & blood components. However, Asia-Pacific is anticipated to grow at a highest growth rate due to rise in government initiatives for the improvement of the healthcare facilities and increase in the number of blood banks.

Blood Market for Mexico, 2016-2023 ($Million)

Key Benefits for Stakeholders

The study provides an in-depth analysis of the global blood market and current trends and future estimations to elucidate the imminent investment pockets.
The report provides a quantitative analysis of the industry from 2016 to 2023 to enable the stakeholders to capitalize on the prevailing market opportunities.
Extensive analysis of the market based on surgeries and products elucidates various trends and prevailing opportunities across segments.
Key market players operating are profiled to determine the competitive outlook of the market by studying the different products of the companies and their developments.
The key players profiled in the report include Abbott Laboratories, Baxter International Inc., Becton, Dickinson & Co., CSL Behring, Immucor, Novartis, Novo Nordisk, Ortho Clinical Diagnostics, Roche Diagnostics, and Grifols International SA.
List of the other players (not included in the report) Medimmune (AstraZeneca), Fresenius Kabi, Macopharma, Nipro Medical Corporation, Sarstedt AG & Co., and Thermo Fisher Scientific, Inc.

Blood Market Key Segments:

By Product

Whole Blood Collection
- Whole Blood Collection Systems
- Whole Blood Collection Reagents
Source Plasma Collections
- Source Plasma Collection Systems
- Source Plasma Collection Reagents
Blood Therapeutics
- IVIG (Intravenous Immunoglobulin)
- Factor IX
- Factor VIII
- Hyperimmune
- Albumins
- Others
Blood Typing Products
- Blood Typing Systems
- Blood Typing Reagents
Blood Screening
- Blood Screening Systems
- Blood Screening Reagents
Blood Processing Equipment & Associated Products
- Blood Processing Equipment Systems
- Blood Processing Equipment Reagents

By End User

Blood & Blood Component Bank
Diagnostic Laboratories
Ambulatory Surgical Centers
Hospitals
Others (Academic Institutes & Research Laboratories)

By Geography

North America
- U.S.
- Canada
- Mexico
Europe
- UK
- France
- Germany
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- Japan
- China
- India
- Rest of Asia-Pacific
LAMEA
- Latin America
- Middle East
- Africa

Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

Chapter: 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top winning strategies
3.2.2. Top investment pockets

3.3. MARKET SHARE ANALYSIS,2016
3.4. PORTERS FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS

3.5.1. Drivers

3.5.1.1. Increase in geriatric population
3.5.1.2. Technological advancement in medical technology for donor screening
3.5.1.3. Advancement in blood transfusion instruments

3.5.2. Restraints

3.5.2.1. Advancement in minimal invasive technology

3.5.3. Opportunities

3.5.3.1. Improvement in the healthcare facilities in Asia-Pacific

Chapter: 4 BLOOD MARKET, BY PRODUCT

4.1. OVERVIEW
4.2. WHOLE BLOOD COLLECTION

4.2.1. Key market trends
4.2.2. Key growth factors and opportunities
4.2.3. Market size and forecast
4.2.4. Market by whole blood collection type

4.2.4.1. Whole Blood Collection Systems

4.2.4.1.1. Market size and forecast

4.2.4.2. Whole Blood Collection Reagents

4.2.4.2.1. Market size and forecast

4.3. SOURCE PLASMA COLLECTION

4.3.1. Key market trends
4.3.2. Key growth factors and opportunities
4.3.3. Market size and forecast
4.3.4. Source Plasma Collection Systems

4.3.4.1. Market size and forecast

4.3.5. Source Plasma Collection Reagents

4.3.5.1. Market size and forecast

4.4. BLOOD THERAPEUTICS

4.4.1. Key market trends
4.4.2. Key growth factors and opportunities
4.4.3. Market size and forecast
4.4.4. IVIG (Intravenous Immunoglobulin)

4.4.4.1. Market size and forecast

4.4.5. Factor IX

4.4.5.1. Market size and forecast

4.4.6. Factor VIII

4.4.6.1. Market size and forecast

4.4.7. Factor IX

4.4.7.1. Market size and forecast

4.4.8. Hyperimmune

4.4.8.1. Market size and forecast

4.4.9. Albumins

4.4.9.1. Market size and forecast

4.4.10. Others

4.4.10.1. Market size and forecast

4.5. BLOOD TYPING PRODUCTS

4.5.1. Key market trends
4.5.2. Key growth factors and opportunities
4.5.3. Market size and forecast
4.5.4. Blood Typing Systems

4.5.4.1. Market size and forecast

4.5.5. Blood Typing Reagents

4.5.5.1. Market size and forecast

4.6. BLOOD SCREENING

4.6.1. Key market trends
4.6.2. Key growth factors and opportunities
4.6.3. Market size and forecast
4.6.4. Blood Screening Systems

4.6.4.1. Market size and forecast

4.6.5. Blood Screening Reagents

4.6.5.1. Market size and forecast

4.7. BLOOD PROCESSING EQUIPMENT AND ASSOCIATED PRODUCTS

4.7.1. Key market trends
4.7.2. Key growth factors and opportunities
4.7.3. Market size and forecast
4.7.4. Blood Processing Equipment Systems

4.7.4.1. Market size and forecast

4.7.5. Blood Processing Equipment Reagents

4.7.5.1. Market size and forecast

Chapter: 5 BLOOD MARKET, BY END USER

5.1. OVERVIEW
5.2. BLOOD & BLOOD COMPONENT BANK

5.2.1. Market size and forecast

5.3. DIAGNOSTIC LABORATORIES

5.3.1. Market size and forecast

5.4. AMBULATORY SURGICAL CENTERS

5.4.1. Market size and forecast

5.5. HOSPITALS

5.5.1. Market size and forecast

Chapter: 6 BLOOD MARKET, BY GEOGRAPHY

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. NORTH AMERICA

6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. Market size and forecast
6.2.4. U.S.: market size and forecast
6.2.5. Canada: market size and forecast
6.2.6. Mexico: market size and forecast

6.3. EUROPE

6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Market size and forecast
6.3.4. Germany: market size and forecast
6.3.5. France market size and forecast
6.3.6. UK: market size and forecast
6.3.7. Italy: market size and forecast
6.3.8. Spain: market size and forecast
6.3.9. Rest of Europe: market size and forecast

6.4. ASIA-PACIFIC

6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Market size and forecast
6.4.4. Japan: market size and forecast
6.4.5. China market size and forecast
6.4.6. India: market size and forecast
6.4.7. Rest of Asia-Pacific market size and forecast

6.5. LAMEA

6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. Market size and forecast
6.5.4. Latin America: market size and forecast
6.5.5. Middle East market size and forecast
6.5.6. Africa: market size and forecast

Chapter: 7 COMPANY PROFILES

7.1. ABBOTT LABORATORIES

7.1.1. Overview
7.1.1. Operating business segments
7.1.1. Business performance
7.1.2. Key strategic moves & developments

7.2. BAXTER INTERNATIONAL INC.

7.2.1. Overview
7.2.2. Operating business segments
7.2.3. Business performance
7.2.4. Key strategic moves & developments

7.3. BECTON, DICKINSON & CO.

7.3.1. Overview
7.3.2. Operating business segments
7.3.3. Business performance
7.3.4. Key strategic moves & developments

7.4. CSL BEHRING

7.4.1. Overview
7.4.2. Operating business segments
7.4.3. Business performance
7.4.4. Key strategic moves & developments

7.5. IMMUCOR

7.5.1. Overview
7.5.2. Operating business segments
7.5.3. Business performance
7.5.4. Key strategic moves & developments

7.6. NOVARTIS

7.6.1. Overview
7.6.2. Operating business segments
7.6.3. Business performance
7.6.4. Key strategic moves & developments

7.7. NOVO NORDISK

7.7.1. Overview
7.7.2. Operating business segments
7.7.3. Business performance
7.7.4. Key strategic moves & developments

7.8. ORTHO CLINICAL DIAGNOSTICS

7.8.1. Overview
7.8.2. Operating business segments
7.8.3. Business performance
7.8.4. Key strategic moves & developments

7.9. ROCHE DIAGNOSTICS

7.9.1. Overview
7.9.2. Operating business segments
7.9.3. Business performance
7.9.4. Key strategic moves & developments

7.10. GRIFOLS INTERNATIONAL SA

7.10.1. Overview
7.10.2. Operating business segments
7.10.3. Business performance
7.10.4. Key strategic moves & developments

LIST OF TABLES

TABLE 1. GLOBAL BLOOD MARKET, BY PRODUCT, 2016-2023, ($ MILLION)
TABLE 2. GLOBAL BLOOD MARKET FOR WHOLE BLOOD COLLECTION, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 3. GLOBAL WHOLE BLOOD COLLECTION MARKET, BY TYPE, 2016-2023, ($ MILLION)
TABLE 4. GLOBAL WHOLE BLOOD COLLECTION SYSTEMS MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 5. GLOBAL WHOLE BLOOD COLLECTION REAGENTS MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 6. GLOBAL BLOOD INDUSTRY MARKET FOR SOURCE PLASMA COLLECTION, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 7. GLOBAL SOURCE PLASMA COLLECTION SYSTEMS, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 8. GLOBAL SOURCE PLASMA COLLECTION REAGENTS , BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 9. GLOBAL BLOOD INDUSTRY MARKET FOR BLOOD THERAPEUTICS, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 10. GLOBAL IVIG (INTRAVENOUS IMMUNOGLOBULIN), BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 11. GLOBAL FACTOR IX, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 12. GLOBAL FACTOR VIII, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 13. GLOBAL FACTOR IX, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 14. GLOBAL HYPERIMMUNE, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 15. GLOBAL ALBUMINS, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 16. GLOBAL OTHERS, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 17. GLOBAL BLOOD MARKET FOR BLOOD TYPING PRODUCTS, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 18. GLOBAL BLOOD TYPING SYSTEMS, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 19. GLOBAL BLOOD TYPING REAGENTS , BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 20. GLOBAL BLOOD MARKET FOR BLOOD SCREENING, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 21. GLOBAL BLOOD SCREENING SYSTEMS, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 22. GLOBAL BLOOD SCREENING REAGENTS , BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 23. GLOBAL BLOOD MARKET FOR BLOOD PROCESSING EQUIPMENT AND ASSOCIATED PRODUCTS, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 24. GLOBAL BLOOD PROCESSING EQUIPMENT SYSTEMS, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 25. GLOBAL BLOOD PROCESSING EQUIPMENT REAGENTS , BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 26. GLOBAL BLOOD MARKET, BY END USER, 2016-2023 ($ MILLION)
TABLE 27. GLOBAL BLOOD MARKET FOR BLOOD & BLOOD COMPONENT BANK, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 28. GLOBAL BLOOD MARKET FOR DIAGNOSTIC LABORATORIES, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 29. GLOBAL BLOOD FOR AMBULATORY SURGICAL CENTERS, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 30. GLOBAL BLOOD MARKET FOR HOSPITALS, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 31. GLOBAL BLOOD MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 32. NORTH AMERICA: BLOOD MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 33. NORTH AMERICA: BLOOD MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 34. NORTH AMERICA: BLOOD MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 35. EUROPE: BLOOD MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 36. EUROPE: BLOOD MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 37. EUROPE: BLOOD MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 38. ASIA-PACIFIC: BLOOD MARKET, BY COUNTRY, 2016-2023($MILLION)
TABLE 39. ASIA-PACIFIC: BLOOD MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 40. ASIA-PACIFIC: BLOOD MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 41. LAMEA: BLOOD MARKET, BY COUNTRY, 2016-2023($MILLION)
TABLE 42. LAMEA: BLOOD MARKET, BY PRODUCT, 2016-2023 ($MILLION)
TABLE 43. LAMEA: BLOOD MARKET, BY END USER, 2016-2023 ($MILLION)
TABLE 44. ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 45. BAXTER INTERNATIONAL INC.: COMPANY SNAPSHOT
TABLE 46. BECTON, DICKINSON & CO.: COMPANY SNAPSHOT
TABLE 47. CSL BEHRING.: COMPANY SNAPSHOT
TABLE 48. IMMUCOR: COMPANY SNAPSHOT
TABLE 49. NOVARTIS: COMPANY SNAPSHOT
TABLE 50. NOVO NORDISK: COMPANY SNAPSHOT
TABLE 51. ORTHO CLINICAL DIAGNOSTICS: COMPANY SNAPSHOT
TABLE 52. ROCHE DIAGNOSTICS: COMPANY SNAPSHOT
TABLE 53. GRIFOLS INTERNATIONAL SA: COMPANY SNAPSHOT

LIST OF FIGURES

FIGURE 1. BLOOD MARKET: MARKET SEGMENTATION
FIGURE 2. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION, (2014-2016)
FIGURE 3. TOP WINNING STRATEGIES: NATURE AND TYPE
FIGURE 4. TOP COMPANIES AND THEIR STRATEGIES
FIGURE 5. DETAILED STRUCTURE OF COMPANIES AND NATURE OF STRATEGIES
FIGURE 6. TOP INVESTMENT POCKETS IN BLOOD MARKET
FIGURE 7. MARKET SHARE ANALYSIS: BLOOD MARKET, 2016
FIGURE 13. U.S.: BLOOD MARKET, 2016-2023($MILLION)
FIGURE 14. CANADA: BLOOD MARKET, 2016-2023($MILLION)
FIGURE 15. MEXICO: BLOOD MARKET, 2016-2023($MILLION)
FIGURE 16. GERMANY: BLOOD MARKET, 2016-2023($MILLION)
FIGURE 17. FRANCE: BLOOD MARKET, 2016-2023($MILLION)
FIGURE 18. UK: BLOOD MARKET, 2016-2023($MILLION)
FIGURE 19. ITALY: BLOOD MARKET, 2016-2023($MILLION)
FIGURE 20. SPAIN: BLOOD MARKET, 2016-2023($MILLION)
FIGURE 21. REST OF EUROPE: BLOOD INDUSTRY MARKET, 2016-2023($MILLION)
FIGURE 22. JAPAN: BLOOD MARKET, 2016-2023($MILLION)
FIGURE 23. CHINA: BLOOD MARKET, 2016-2023($MILLION)
FIGURE 24. INDIA: BLOOD MARKET, 2016-2023($MILLION)
FIGURE 25. REST OF ASIA-PACIFIC: BLOOD MARKET, 2016-2023($MILLION)
FIGURE 26. LATIN AMERICA: BLOOD MARKET, 2016-2023($MILLION)
FIGURE 27. MIDDLE EAST: BLOOD MARKET, 2016-2023($MILLION)
FIGURE 28. AFRICA: BLOOD MARKET, 2016-2023($MILLION)
FIGURE 29. ABBOTT LABORATORIES: REVENUE, 2013-2015 ($MILLION)
FIGURE 30. BAXTER INTERNATIONAL INC.: REVENUE, 2013-2015 ($MILLION)
FIGURE 31. BECTON, DICKINSON & CO.: REVENUE, 2013-2015 ($MILLION)
FIGURE 32. CSL BEHRING: REVENUE, 2013-2015 ($MILLION)
FIGURE 33. IMMUCOR: REVENUE, 2013-2015 ($MILLION)
FIGURE 34. NOVARTIS: REVENUE, 2013-2015 ($MILLION)
FIGURE 35. NOVO NORDISK: REVENUE, 2013-2015 ($MILLION)
FIGURE 36. ORTHO CLINICAL DIAGNOSTICS: REVENUE, 2013-2015 ($MILLION)
FIGURE 37. ROCHE DIAGNOSTICS: REVENUE, 2013-2015 ($MILLION)
FIGURE 38. GRIFOLS INTERNATIONAL SA: REVENUE, 2013-2015 ($MILLION)

Blood transfusion is sometimes necessary after an injury or surgery that causes high amount of blood loss. Some people need regular transfusions, which is known as transfusion therapy, due to medical conditions, such as hemophilia or cancer. Blood industry involves sale of whole blood & blood components through various channels, such as blood banks, hospitals, and others. The donor blood is collected and segregated into required components.

Increase in geriatric population, technological advancement in medical technology for donor screening, and advancement in blood transfusion instruments are the major factors that drive the market growth. However, rise in minimal invasive technology, which no longer requires blood transfusion, hinders the market growth. Increase in peripheral nerve injuries and improvement in the healthcare facilities in Asia-Pacific provide growth opportunities for the market.

According to the National Heart, Lung, and Blood Institute, about 5 million Americans need a blood transfusion each year. Each day, thousands of patients worldwide with leukemia, aplastic anemia, and other fatal blood diseases are in a need of life-saving match. New York Blood Center (NYBC) receives over 10-15 new requests a day for potential donors to undergo additional testing in a hope of providing a perfect transplant match.